Drugs / CD34 Positive Stem Cell Infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02438904 | May 2015 → May 2027 expected | disease related to hematopoietic stem cell transplant | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34 Positive Stem Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02438904 ↗ |
| Modality | Cell therapy | “The therapy that you will receive involves you being given an infusion of CD34 positive stem cells.” NCT02438904 ↗ |
| Route | Intravenous | “The CD34 positive cells will be given by vein” NCT02438904 ↗ |